Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 3045-3053

  Deng, Feiyan ^a   Zhou, Keming ^b   Cui, Wenli ^a   Liu, Dong ^a   Ma, Yuqing ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region Xinjiang Hypertension Institute   (China)

Author keywords

Clinicopathology; Esophageal squamous cell carcinoma; GSK3 ; Immunohistochemistry; Wnt2; catenin

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, HUMAN; TUMOR MARKER; WNT2 PROTEIN; WNT2 PROTEIN, HUMAN;

AGED; BIOSYNTHESIS; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; WNT SIGNALING PATHWAY;

AGED; BETA CATENIN; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; WNT SIGNALING PATHWAY; WNT2 PROTEIN;

EID: 84933034459     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Vallbohmer D, Brabender J, Metzger R, Holscher AH. Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors. J Gastrointest Surg 2010; 14 Suppl 1: S75-80.
2. Zhang P, Xi M, Li QQ, He LR, Liu SL, Zhao L, Shen JX, Liu MZ. The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer 2014; 5: 689-695.
3. Wang AH, Liu Y, Wang B, He YX, Fang YX, Yan YP. Epidemiological studies of esophageal cancer in the era of genome-wide association studies. World J Gastrointest Pathophysiol 2014; 5: 335-343.
4. Cui XB, Chen YZ, Pang XL, Liu W, Hu JM, Li SG, Yang L, Zhang WJ, Liu CX, Cao YW, Jiang JF, Gu WY, Pang J, Yang L, Yuan XL, Yu SY, Li F. Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population. Gene 2013; 530: 315-322.
5. Chai J, Modak C, Ouyang Y, Wu SY, Jamal MM. CCN1 induces β-Catenin translocation in esophageal squamous cell carcinoma through integrina11. ISRN Gastroenterol 2012; 2012: 207235.
6. Behrens J, Lustig B. The Wnt connection to tumorigenesis. Int J Dev Biol 2004; 48: 477-487.
7. Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 2012; 4: a008052.
8. Widelitz R. Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 2005; 23: 111-6.
9. Fu L, Zhang C, Zhang LY, Dong SS, Lu LH, Chen J, Dai Y, Li Y, Kong KL, Kwong DL, Guan XY. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. Gut 2011; 60: 1635-1643.
10. Zhang C, Fu L, Fu J, Hu L, Yang H, Rong TH, Li Y, Liu H, Fu SB, Zeng YX, Guan XY. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res 2009; 15: 4017-27.
11. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis a look outside the nucleus. Science 2000; 287: 1606-1609.
12. Gkretsi V, Zhang Y, Tu Y, Chen K, Stolz DB, Yang Y, Watkins SC, Wu C. Physical and functional association of migfilin with cell-cell adhesions. J Cell Sci 2005; 118: 697-710.
13. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9: 15-21.
14. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004; 10: 5455-5463.
15. Willert K, Jones KA. Wnt signaling: is the party in the nucleus? Genes Dev 2006; 20: 1394-404.
16. Krieghoff E, Behrens J, Mayr B. Nucleo-cytoplasmic distributionof β-catenin is regulated by retention. J Cell Sci 2006; 119: 1453-63.
17. Ishiguro H, Furukawa Y, Daigo Y, Miyoshi Y, Nagasawa Y, Nishiwaki T, Kawasoe T, Fujita M, Satoh S, Miwa N, Fujii Y, Nakamura Y. Isolation and characterization of human NBL4, a gene involved in the betacatenin/tcf signaling pathway. Jpn J Cancer Res 2000; 91: 597-603.
18. Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 2010; 35: 161-168.
19. Tang X, Zheng D, Hu P, Zeng Z, Li M, Tucker L, Monahan R, Resnick MB, Liu M, Ramratnam B. Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells. Nucleic Acids Res 2014; 42: 2988-98.
20. Hsu PK, Wu YC, Chou TY, Huang CS, Hsu WH. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg 2010; 89: 1024-1031.
21. Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L, Li SQ. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Med Oncol 2012; 29: 151-160.
22. Kim MS, Chang XF, Cynthia LeBron, Nagpal JK, Lee J, Huang YP, KeishiYamashita, Trink B, Ratovitski EA, Sidransky D. Neurofilament heavy polypeptide regulates the akt-β-catenin pathway in human esophageal squamous cell carcinoma. PLoS One 2010; 5: 9003.
23. Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST. Epigeneticin activation of secreted frizzled-related protein2 in esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18: 532-540.
24. Wang W, Xue L, Wang P. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma. Med Oncol 2011; 28: 163-169.
25. Huang L, Lu Q, Han Y, Li Z, Zhang Z, Li X. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells. Diagn Pathol 2012; 7: 1746-1596.
26. He H, Ding F, Li Y, Luo A, Chen H, Wu C, Liu Z. Migfilin regulates esophageal cancer cell motility through promoting GSK-3b-mediated degradation of β-catenin. Mol Cancer Res 2012; 10: 273-81.
27. Anastas JN, Moon RT. WNT signaling pathways as therapeutic target in cancer. Nat Rev Cancer 2013; 13: 11-26.
28. Park JK, Song JH, He TC, Nam SW, Lee JY, Park WS. Overexpression of Wnt-2 in colorectal cancers. Neoplasma 2009; 56: 119-23.
29. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, Gao X, Guan HW, Li H. Frequent loss of membranous E-cadherin in gastric cancers: a cross-talk with Wnt in determining the fate of beta-catenin. Clin Exp Metastasis 2005; 22: 85-93.
30. Clement G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene 2006; 25: 3084-92.
31. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42.
32. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.
33. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480.
34. Xu X, Sun PL, Li JZ, Jheon S, Lee CT, Chung JH. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. J Thorac Oncol 2011; 6: 716-724.
35. Abrahamsson AE, Geron I, Gotlib J, Dao KH, Barroga CF, Newton IG, Giles FJ, Durocher J, Creusot RS, Karimi M, Jones C, Zehnder JL, Keating A, Negrin RS, Weissman IL, Jamieson CH. Glycogen synthase kinase 3bmissplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci U S A 2009; 106: 3925-3929.
36. Nusse R. Wnt Signaling. Cold Spring Harb Perspect Biol 2012; 4: a011163.
37. Hsu P, Li A, Wang Y, Hsieh CC, Huang MH, Hsu WH, Hsu HS. Reduced membranous β-catenin protein expression is associated with metastasis and poor prog-nosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg 2008; 135: 1029-35.
38. Ninomiya I, Endo Y, Fushida S, Sasagawa T, Miyashita T, Fujimura T, Nishimura G, Tani T, Hashimoto T, Yagi M, Shimizu K, Ohta T, Yonemura Y, Inoue M, Sasaki T, Miwa K. Alteration of beta-catenin expression in esophageal squamous-cell carcinoma. Int J Cancer 2000; 85: 757-61.